Historical record - last NADAC effective date: 5/18/2016
Product Information
PROTONIX IV 40 MG VIAL is a brand product labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., priced at $3.7944 per EA under NDC 00008092355. Its NADAC has been published 105 times since Jun 17, 2015.
FDA first approved this application on Mar 22, 2001. Its Orange Book therapeutic-equivalence code is AP.
The High Outlier badge above means this manufacturer's average price in the PANTOPRAZOLE SODIUM market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/10mL
NDC
00008092355
Classification
Brand
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS
Effective Date
5/18/2016
Active Ingredients
PANTOPRAZOLE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA020988FDA Approved
3/22/2001
TE Code
AP
On Market Since
5/1/2001
Pharmacological Classes
Price Statistics
The NADAC for PROTONIX IV 40 MG VIAL has been published 105 times since Jun 17, 2015, and over the history we have for it it has declined 17.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.7944 per EA |
|---|---|
| All-time high | $4.6192 (May 11, 2016) |
| All-time low | $3.7944 (May 18, 2016) |
| Median price | $3.7944 |
| Average price | $4.1715 |
| Largest weekly change | -17.9% (May 18, 2016) |
| Weeks tracked | 105 |
| Tracking since | Jun 17, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-17.9%
Last surveyed Jun 14, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 51% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PROTONIX IV 40 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for PROTONIX IV 40 MG VIAL, manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., is $3.7944 per EA (NDC 00008092355), effective Jun 14, 2017.
How has the price of PROTONIX IV 40 MG VIAL changed over time?
Over the history we have for it, the NADAC for PROTONIX IV 40 MG VIAL has declined 17.9%. It has been tracked across 105 weekly CMS publications since Jun 17, 2015.
What are the highest and lowest recorded NADAC prices for PROTONIX IV 40 MG VIAL?
Since Jun 17, 2015, the NADAC for PROTONIX IV 40 MG VIAL has ranged from a low of $3.7944 (May 18, 2016) to a high of $4.6192 (May 11, 2016), with a median of $3.7944 per EA.
Are there cheaper alternatives to PROTONIX IV 40 MG VIAL?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PANTOPRAZOLE SODIUM 40 MG VIAL, is $1.8514 per EA — about 51% below PROTONIX IV 40 MG VIAL.
Who manufactures PROTONIX IV 40 MG VIAL?
PROTONIX IV 40 MG VIAL (NDC 00008092355) is labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., and CMS classifies it as a brand product.